| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adaptor Proteins, Signal Transducing | 11 | 2021 | 552 | 1.560 |
Why?
|
| Arrestins | 13 | 2003 | 28 | 1.180 |
Why?
|
| Transcription Factors | 16 | 2021 | 2588 | 1.150 |
Why?
|
| LIM Domain Proteins | 8 | 2013 | 60 | 1.090 |
Why?
|
| Lysophospholipids | 8 | 2012 | 29 | 1.050 |
Why?
|
| Cell Movement | 6 | 2013 | 847 | 0.870 |
Why?
|
| Carrier Proteins | 13 | 2021 | 1021 | 0.860 |
Why?
|
| Receptors, Lysophosphatidic Acid | 6 | 2012 | 10 | 0.850 |
Why?
|
| DNA-Binding Proteins | 17 | 2021 | 2046 | 0.810 |
Why?
|
| Nuclear Proteins | 14 | 2021 | 1265 | 0.700 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 234 | 0.660 |
Why?
|
| Apoptosis | 12 | 2014 | 1806 | 0.630 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 9 | 2021 | 67 | 0.560 |
Why?
|
| Phosphorylation | 20 | 2021 | 1631 | 0.550 |
Why?
|
| Actins | 3 | 2021 | 346 | 0.540 |
Why?
|
| Signal Transduction | 13 | 2021 | 4534 | 0.500 |
Why?
|
| E2F1 Transcription Factor | 9 | 2020 | 48 | 0.480 |
Why?
|
| Proteasome Endopeptidase Complex | 8 | 2013 | 263 | 0.460 |
Why?
|
| Receptors, Adrenergic, beta-2 | 5 | 2002 | 84 | 0.450 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2011 | 212 | 0.440 |
Why?
|
| Endocytosis | 6 | 2003 | 125 | 0.430 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 2512 | 0.420 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 60 | 0.410 |
Why?
|
| Protein Binding | 12 | 2020 | 1757 | 0.380 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 618 | 0.360 |
Why?
|
| Transcriptional Activation | 3 | 2011 | 487 | 0.350 |
Why?
|
| fas Receptor | 1 | 2010 | 41 | 0.350 |
Why?
|
| Cell Cycle Proteins | 9 | 2021 | 657 | 0.350 |
Why?
|
| Down-Regulation | 4 | 2012 | 698 | 0.320 |
Why?
|
| Cell Line, Tumor | 12 | 2021 | 3348 | 0.300 |
Why?
|
| beta-Arrestins | 13 | 2003 | 30 | 0.300 |
Why?
|
| Cell Line | 16 | 2020 | 2758 | 0.280 |
Why?
|
| Gene Expression Regulation | 7 | 2007 | 2522 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 489 | 0.280 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 70 | 0.280 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 78 | 0.270 |
Why?
|
| Mice | 25 | 2021 | 17632 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 558 | 0.250 |
Why?
|
| Animals | 32 | 2021 | 34219 | 0.240 |
Why?
|
| DNA Repair | 3 | 2021 | 585 | 0.240 |
Why?
|
| DNA Damage | 7 | 2021 | 513 | 0.230 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 5 | 2021 | 96 | 0.230 |
Why?
|
| Ovarian Neoplasms | 3 | 2021 | 419 | 0.230 |
Why?
|
| Receptors, Opioid, mu | 2 | 2000 | 30 | 0.210 |
Why?
|
| Clathrin | 2 | 2002 | 24 | 0.210 |
Why?
|
| DNA Replication | 4 | 2021 | 352 | 0.200 |
Why?
|
| Morphine | 2 | 2000 | 83 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 725 | 0.200 |
Why?
|
| HEK293 Cells | 4 | 2014 | 735 | 0.200 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2012 | 292 | 0.200 |
Why?
|
| NIH 3T3 Cells | 4 | 2007 | 91 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2020 | 50 | 0.200 |
Why?
|
| src-Family Kinases | 3 | 2011 | 90 | 0.200 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 118 | 0.200 |
Why?
|
| Checkpoint Kinase 1 | 2 | 2021 | 24 | 0.200 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2021 | 27 | 0.180 |
Why?
|
| Transfection | 9 | 2008 | 1068 | 0.180 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 119 | 0.170 |
Why?
|
| Cell Adhesion | 3 | 2014 | 344 | 0.170 |
Why?
|
| 14-3-3 Proteins | 2 | 2014 | 54 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2000 | 89 | 0.170 |
Why?
|
| Disease Progression | 2 | 2022 | 2064 | 0.170 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 2 | 2011 | 8 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2017 | 723 | 0.160 |
Why?
|
| Humans | 36 | 2022 | 125167 | 0.160 |
Why?
|
| Adipocytes | 3 | 1996 | 141 | 0.160 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2014 | 68 | 0.160 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 209 | 0.160 |
Why?
|
| Analgesics, Opioid | 2 | 2000 | 404 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 356 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2021 | 333 | 0.150 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1998 | 93 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 546 | 0.150 |
Why?
|
| Tyrosine | 2 | 2010 | 154 | 0.140 |
Why?
|
| Amino Acid Motifs | 4 | 2020 | 200 | 0.140 |
Why?
|
| Casein Kinase II | 2 | 2011 | 13 | 0.140 |
Why?
|
| Glioma | 2 | 2013 | 492 | 0.140 |
Why?
|
| Enzyme Activation | 5 | 2008 | 628 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2021 | 557 | 0.130 |
Why?
|
| Serine | 4 | 2002 | 175 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 668 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 3 | 2014 | 620 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2020 | 838 | 0.120 |
Why?
|
| Mice, Nude | 2 | 2014 | 708 | 0.120 |
Why?
|
| Models, Biological | 3 | 2010 | 1460 | 0.120 |
Why?
|
| rho Guanine Nucleotide Dissociation Inhibitor alpha | 1 | 2014 | 10 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1893 | 0.110 |
Why?
|
| Gene Expression | 3 | 2021 | 1561 | 0.110 |
Why?
|
| Cytosol | 2 | 2013 | 162 | 0.110 |
Why?
|
| Ubiquitin | 2 | 2012 | 141 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2013 | 676 | 0.110 |
Why?
|
| Zyxin | 1 | 2013 | 5 | 0.100 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 16 | 0.100 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2013 | 39 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 63 | 0.100 |
Why?
|
| Mitosis | 1 | 1993 | 237 | 0.100 |
Why?
|
| Adipose Tissue | 2 | 1994 | 466 | 0.100 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 65 | 0.100 |
Why?
|
| Molecular Sequence Data | 7 | 2009 | 3891 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2009 | 2715 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2017 | 875 | 0.100 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 256 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 28 | 0.100 |
Why?
|
| Radiation Tolerance | 1 | 2012 | 48 | 0.100 |
Why?
|
| Cell Differentiation | 4 | 1996 | 1896 | 0.100 |
Why?
|
| 3T3 Cells | 5 | 1996 | 121 | 0.100 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 5 | 1996 | 49 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 686 | 0.090 |
Why?
|
| S Phase | 4 | 2020 | 73 | 0.090 |
Why?
|
| Focal Adhesions | 1 | 2011 | 14 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 662 | 0.090 |
Why?
|
| STAT Transcription Factors | 1 | 2011 | 23 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 171 | 0.090 |
Why?
|
| Telomere Homeostasis | 1 | 2011 | 42 | 0.090 |
Why?
|
| Osteoclasts | 1 | 2011 | 55 | 0.090 |
Why?
|
| Receptors, Angiotensin | 2 | 2001 | 21 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 90 | 0.090 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2010 | 6 | 0.090 |
Why?
|
| Polycythemia Vera | 1 | 2011 | 39 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 140 | 0.090 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2011 | 121 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1660 | 0.090 |
Why?
|
| Transcription Factor RelA | 1 | 2010 | 54 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 117 | 0.090 |
Why?
|
| Mice, Knockout | 6 | 2021 | 3744 | 0.090 |
Why?
|
| Phosphoproteins | 3 | 2012 | 417 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2011 | 185 | 0.080 |
Why?
|
| beta-Arrestin 2 | 5 | 2001 | 12 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2013 | 868 | 0.080 |
Why?
|
| Doxorubicin | 6 | 2009 | 290 | 0.080 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1694 | 0.080 |
Why?
|
| Telomere | 1 | 2011 | 213 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2004 | 65 | 0.080 |
Why?
|
| Triglycerides | 1 | 1992 | 575 | 0.080 |
Why?
|
| Glutathione Transferase | 3 | 2004 | 155 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2013 | 330 | 0.080 |
Why?
|
| Neoplasms | 2 | 2014 | 2794 | 0.080 |
Why?
|
| GTP-Binding Proteins | 4 | 2009 | 179 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2011 | 459 | 0.080 |
Why?
|
| COS Cells | 4 | 2002 | 275 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2000 | 207 | 0.080 |
Why?
|
| RNA | 1 | 1992 | 570 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2001 | 158 | 0.080 |
Why?
|
| Female | 7 | 2022 | 66783 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 286 | 0.070 |
Why?
|
| Cell Division | 2 | 2020 | 782 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 1290 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 132 | 0.070 |
Why?
|
| Chromatin | 2 | 2021 | 553 | 0.070 |
Why?
|
| Protein Phosphatase 1 | 1 | 2007 | 51 | 0.070 |
Why?
|
| Mutation | 6 | 2009 | 5842 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 151 | 0.070 |
Why?
|
| Ubiquitination | 2 | 2021 | 167 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 2 | 2008 | 271 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 658 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2003 | 155 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2017 | 399 | 0.060 |
Why?
|
| beta-Arrestin 1 | 3 | 2001 | 4 | 0.060 |
Why?
|
| Cisplatin | 3 | 2021 | 249 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 388 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2012 | 314 | 0.060 |
Why?
|
| Isoproterenol | 2 | 2002 | 106 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2003 | 767 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2008 | 468 | 0.060 |
Why?
|
| Base Pair Mismatch | 1 | 2004 | 21 | 0.060 |
Why?
|
| DNA | 4 | 2004 | 1608 | 0.060 |
Why?
|
| DNA Repair Enzymes | 1 | 2004 | 39 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 1994 | 981 | 0.060 |
Why?
|
| Protein Kinases | 2 | 2021 | 330 | 0.060 |
Why?
|
| Paxillin | 1 | 2003 | 13 | 0.060 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 24 | 0.060 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 25 | 0.060 |
Why?
|
| Fibroblasts | 4 | 2012 | 878 | 0.060 |
Why?
|
| Point Mutation | 2 | 2002 | 348 | 0.050 |
Why?
|
| E2F Transcription Factors | 4 | 2004 | 24 | 0.050 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2000 | 29 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 201 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 156 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 4 | 2008 | 1329 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2003 | 88 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 513 | 0.050 |
Why?
|
| Threonine | 1 | 2002 | 60 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 331 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2002 | 29 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 1112 | 0.050 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2002 | 62 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2003 | 1398 | 0.050 |
Why?
|
| CHO Cells | 3 | 2012 | 169 | 0.050 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2021 | 6 | 0.050 |
Why?
|
| Cricetinae | 3 | 2012 | 422 | 0.050 |
Why?
|
| Mutagenesis | 2 | 2003 | 346 | 0.040 |
Why?
|
| Carcinogens | 1 | 2021 | 152 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2000 | 37 | 0.040 |
Why?
|
| Drug Tolerance | 1 | 2000 | 40 | 0.040 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 2012 | 40 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2000 | 45 | 0.040 |
Why?
|
| DNA Adducts | 1 | 2021 | 77 | 0.040 |
Why?
|
| Binding Sites | 2 | 2002 | 1304 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 74 | 0.040 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 17 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 1064 | 0.040 |
Why?
|
| G2 Phase | 1 | 2020 | 44 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2004 | 772 | 0.040 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1999 | 2 | 0.040 |
Why?
|
| E2F3 Transcription Factor | 3 | 2004 | 11 | 0.040 |
Why?
|
| Sumoylation | 1 | 2020 | 37 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 55 | 0.040 |
Why?
|
| Pain Threshold | 1 | 1999 | 20 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2004 | 797 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 302 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 668 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2021 | 229 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2020 | 114 | 0.040 |
Why?
|
| Cyclins | 1 | 2020 | 101 | 0.040 |
Why?
|
| Naloxone | 1 | 1999 | 48 | 0.040 |
Why?
|
| Analgesia | 1 | 1999 | 42 | 0.040 |
Why?
|
| Peptide Mapping | 1 | 1999 | 44 | 0.040 |
Why?
|
| Body Temperature | 1 | 1999 | 118 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 1994 | 1700 | 0.040 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1999 | 6 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1999 | 43 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 1999 | 109 | 0.040 |
Why?
|
| Feedback | 1 | 1999 | 164 | 0.040 |
Why?
|
| Pain Measurement | 1 | 1999 | 346 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 1999 | 120 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 889 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2020 | 618 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2003 | 4404 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1506 | 0.030 |
Why?
|
| Rats | 4 | 2012 | 3716 | 0.030 |
Why?
|
| Cell Survival | 2 | 2011 | 813 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 581 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2017 | 231 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2014 | 35 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 173 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 376 | 0.030 |
Why?
|
| Growth Inhibitors | 1 | 1993 | 38 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 222 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1993 | 387 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 161 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1994 | 296 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 246 | 0.030 |
Why?
|
| DNA Fragmentation | 1 | 2012 | 54 | 0.030 |
Why?
|
| Apc5 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 2 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2012 | 71 | 0.020 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 20 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 1992 | 15 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 61 | 0.020 |
Why?
|
| Time Factors | 1 | 2002 | 6334 | 0.020 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 97 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1992 | 215 | 0.020 |
Why?
|
| Caspases | 1 | 2012 | 162 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2012 | 165 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1994 | 382 | 0.020 |
Why?
|
| Phosphorylase a | 1 | 2011 | 5 | 0.020 |
Why?
|
| Janus Kinase 1 | 1 | 2011 | 12 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1993 | 352 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 2004 | 96 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 1994 | 2821 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 168 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2001 | 61 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 502 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 432 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2011 | 132 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1992 | 1101 | 0.020 |
Why?
|
| Lipoylation | 1 | 2009 | 4 | 0.020 |
Why?
|
| beta-Adrenergic Receptor Kinases | 2 | 2001 | 26 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2009 | 38 | 0.020 |
Why?
|
| Tumor Protein p73 | 1 | 2008 | 22 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2008 | 29 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1992 | 936 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 311 | 0.020 |
Why?
|
| Brain | 1 | 1999 | 2999 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 236 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 909 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2004 | 3054 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 244 | 0.020 |
Why?
|
| Liver | 1 | 1993 | 1745 | 0.020 |
Why?
|
| Human papillomavirus 16 | 1 | 2006 | 50 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2006 | 109 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 2312 | 0.020 |
Why?
|
| Drug Stability | 1 | 2004 | 58 | 0.010 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2006 | 347 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 335 | 0.010 |
Why?
|
| MutL Proteins | 1 | 2004 | 19 | 0.010 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2004 | 53 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 184 | 0.010 |
Why?
|
| Base Sequence | 2 | 2001 | 3102 | 0.010 |
Why?
|
| G1 Phase | 1 | 2004 | 67 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 26 | 0.010 |
Why?
|
| E2F2 Transcription Factor | 1 | 2003 | 4 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 128 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 2003 | 9 | 0.010 |
Why?
|
| BRCA1 Protein | 1 | 2003 | 68 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 826 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2003 | 180 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2002 | 53 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 897 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2003 | 294 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2003 | 358 | 0.010 |
Why?
|
| Biological Transport | 1 | 2002 | 356 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2002 | 291 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 460 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2001 | 100 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 115 | 0.010 |
Why?
|
| Morphine Dependence | 1 | 2000 | 1 | 0.010 |
Why?
|
| Membranes | 1 | 2000 | 23 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2000 | 7 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 2001 | 31 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Drug Implants | 1 | 2000 | 42 | 0.010 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2001 | 18 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2000 | 40 | 0.010 |
Why?
|
| Adenylyl Cyclases | 1 | 2000 | 83 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 384 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 541 | 0.010 |
Why?
|
| Endosomes | 1 | 2000 | 64 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 247 | 0.010 |
Why?
|
| Brain Stem | 1 | 2000 | 116 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2003 | 571 | 0.010 |
Why?
|
| DNA Primers | 1 | 2001 | 657 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 404 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2000 | 167 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 569 | 0.010 |
Why?
|
| N-Ethylmaleimide-Sensitive Proteins | 1 | 1999 | 1 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1999 | 31 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 1999 | 38 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 95 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1999 | 94 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 111 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 714 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1999 | 282 | 0.010 |
Why?
|
| Calcium | 1 | 2002 | 1102 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1999 | 462 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 470 | 0.010 |
Why?
|
| Kidney | 1 | 2003 | 1365 | 0.010 |
Why?
|
| Kinetics | 1 | 1997 | 1332 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1994 | 44 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 1241 | 0.010 |
Why?
|